[Federal Register Volume 62, Number 210 (Thursday, October 30, 1997)]
[Notices]
[Page 58737]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-28691]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Institute of Allergy and infectious Diseases Special Emphasis 
Panel (SEP) meeting:

    Name of SEP: Integrated Preclinical/Clinical AIDS Vaccine 
Development.
    Date: November 19-21, 1997.
    Time: 8:30 a.m. to Adjournment.
    Place: Holiday Inn Chevy Chase, Chase Room, 5520 Wisconsin 
Avenue, Chevy Chase, MD 20815, (301) 656-1500
    Contact Person: Dr. Vassil Georgiev, Scientific Review Adm., 
6003 Executive Boulevard, Solar Bldg., Room 4C04, Bethesda, MD 
20892, (301) 496-2550.
    Purpose/Agenda: To evaluate grant applications.
    The meeting will be closed in accordance with the provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Programs No. 93.855, 
Immunology, Allergic and Immunologic Disease Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health)

    Dated: October 23, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-28691 Filed 10-29-97; 8:45 am]
BILLING CODE 4140-01-M